Zinc · protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat

https://doi.org/10.1016/0304-4165(81)90465-7Get rights and content

Abstract

The present study was undertaken to examine the liver, spleen and kidney heme oxygenase activity in the rat, and also to investigate the response of the enzyme to a variety of metalloporphyrin complexes. The enzyme activity in the liver and the kidney of 3–4-day-old rats was several-fold greater than the corresponding values in the adult animals; however, the splenic enzyme activity was markedly depressed in comparison to that of adult rats. During the first 2–3 weeks post-parturation period, the activity of heme oxygenase in the spleen progressively increased, and in 4 weeks approached the adult values. The treatment of the newborn animals with the metalloporphyrin complex, Zn · protoporphyrin-IX, inhibited heme oxygenase activity in the spleen, lier and the kidney. Sn · protoporphyrin treatment also inhibited the activity of the enzyme in the liver and the spleen. The mechanism of the inhibition appeared to be competitive in nature. In contrast, the treatment of the newborn animals with Co · protoporphyrin increased the activity of the enzyme in the tested organs. The treatment of newborn animals with Fe · protoporphyrin (heme) also increased heme oxygenase activity in the spleen and the kidney. In addition, Co · and Fe · protoporphyrin complexes inhibited the activity of δ-aminolevulinate synthetase in the spleen; Sn · protoporphyrin and Zn · protoporphyrin, however, did not alter the activity of this enzyme. The effects of Co · protoporphyrin and Zn · protoporphyrin on the microsomal contents of cytochromes P-450, b5, the total heme, and the microsomal drug metabolism activity in the liver were compared. Zn · protoporphrin was ineffective in altering the indicated cellular variables. According to these findings Zn · protoporphyrin may be useful as an experimental tool for the selective suppression of heme degradation activity.

References (44)

  • M.D. Maines et al.

    J. Biol. Chem.

    (1978)
  • J.S. Woods et al.

    Biochem. Pharmacol.

    (1970)
  • S. Granick et al.

    J. Biol. Chem.

    (1963)
  • M.D. Maines et al.

    J. Biol. Chem.

    (1975)
  • A.D. Waxman et al.

    Biochem. Biophys. Res. Commun.

    (1966)
  • M.D. Maines et al.

    J. Biol. Chem.

    (1977)
  • T. Yoshida et al.

    J. Biol. Chem.

    (1978)
  • T. Yoshida et al.

    FEBS Lett.

    (1974)
  • H.S. Marver et al.

    J. Biol. Chem.

    (1966)
  • M.D. Maines et al.

    J. Biol. Chem.

    (1975)
  • T. Omura et al.

    J. Biol. Chem.

    (1964)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • A.J. Paine et al.

    Biochem. Biophys. Res. Commun.

    (1978)
  • M.A. Correia et al.
  • A. Kumar et al.

    J. Biol. Chem.

    (1980)
  • T. Yoshida et al.

    J. Biol. Chem.

    (1978)
  • R. Tenhunen et al.

    J. Biol. Chem.

    (1968)
  • M.M. Thaler et al.

    Pediat. Res.

    (1972)
  • M.D. Maines et al.

    J. Exp. Med.

    (1975)
  • M.D. Maines et al.

    J. Expt. Med.

    (1977)
  • C.R. Short et al.

    Biol. Neonate

    (1972)
  • T.E. Gram et al.

    Biochem. J.

    (1969)
  • Cited by (175)

    • Theoretical (DFT) study on the hydroxylation mechanism of Sn(IV)porphyrin: How does Sn(IV)porphyrin inhibit heme oxygenase catalysis function

      2022, Journal of Molecular Structure
      Citation Excerpt :

      Metalloporphyrins (MPs) known as competitive inhibitors of HO control hyperbilirubinemia via preventation of excessive bilirubin formation [25]. These compounds are heme anlogoues with zinc, tin, and manganese as the central metal ions, and have higher binding affinity than heme to HOs [26,27]. It's supposed that metalloporphyrins by blocking the active site of HO inhibit heme degradation, however, the mechanism of inhibition process has not been obviously understood.

    • Hemin protects against hippocampal damage following orthotopic autologous liver transplantation in adult rats

      2015, Life Sciences
      Citation Excerpt :

      ZnPP pre-treatment group (ZnPP + OALT group), 32 mg/kg zinc protoporphyrin (ZnPP) (Frontier Scientific, Carnforth, Lancashire, UK) was intraperitoneally administrated 24 h before the operation. ZnPP, a competitive inhibitor of HO-1, is an endogenously molecule formed during heme biosynthesis [24], and its level often increases in chronic anemia disorders [14,15]. The time point was chosen based on the results of a previous study showing peak expression of HO-1 at 24 h after the administration of hemin [34].

    • Indomethacin inhibits activation of endothelial nitric oxide synthase in the rat kidney: Possible role of this effect in the pathogenesis of indomethacin-induced renal damage

      2014, Chemico-Biological Interactions
      Citation Excerpt :

      Animals were sacrificed 12 h later. ZnPP (40 μmole/kg body weight) was injected subcutaneously twice a day for 2 days (4 doses) [19]. Indomethacin or vehicle was administered orally along with the third dose of ZnPP and animals were sacrificed 24 h after the indomethacin/vehicle dose.

    View all citing articles on Scopus
    View full text